HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: ptj.20070104v1 88/1/105    most recent Submit a response Alert me when this article is cited Alert me when Rapid Responses are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Pandya, S. Articles by Tawil, R. Search for Related Content PubMed PubMed Citation Articles by Pandya, S. Articles by Tawil, R.

Facioscapulohumeral Dystrophy

S Pandya, PT, MS, is Assistant Professor of Neurology and Physical Medicine and Rehabilitation, School of Medicine and Dentistry, University of Rochester, Rochester, NY 14627 (USA)
WM King, PT, BA, is Clinical Assistant Professor of Neurology, Department of Neurology, Ohio State University, Columbus, Ohio
R Tawil, MD, is Professor of Neurology, Department of Neurology, University of Rochester

Address all correspondence to Ms Pandya at: shree_pandya{at}urmc.rochester.edu

Facioscapulohumeral dystrophy (FSHD) is the third most common inherited muscular dystrophy after Duchenne dystrophy and myotonic dystrophy. Over the last decade, major advances have occurred in the understanding of the genetics of this disorder. Despite these advances, the exact mechanisms that lead to atrophy and weakness secondary to the genetic defect are still not understood. The purposes of this article are to increase awareness of FSHD among clinicians; to provide an update regarding the genetics, clinical features, natural history, and current management of FSHD; and to discuss opportunities for research.